<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Oncolytics Biotech Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Oncolytics Biotech Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Oncolytics_Biotech_Inc-2502831</link>
<lastBuildDate>Thursday, January 08, 2009 2:45:58 PM</lastBuildDate>
<alacra:xlsid>2502831</alacra:xlsid>
<alacra:company>Oncolytics Biotech Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-29666347</link><guid isPermaLink="false">newstex/PRN-0005-29666347</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Nov. ##, #### (PR Newswire delivered by Newstex) -- CALGARY, Nov. ## /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted its ##th U.S. Patent, # #,###,###,...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014008</newstex:cat><pubDate>11/18/2008 8:21:28 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Oncolytics Biotech Inc. Announces Issuance of 30th U.S. Patent</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-29666347</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">CANCER THERAPEUTICS INC.</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ONCOLYTICS BIOTECH INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">CTHP</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ONC</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ONCY</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0001-29666459</link><guid isPermaLink="false">newstex/PRN-0001-29666459</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Nov. ##, #### (Canada NewsWire Group delivered by Newstex) -- CALGARY, Nov. ## /CNW/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted its ##th U.S. Patent, No. #,###,###, entitled...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014008</newstex:cat><pubDate>11/18/2008 8:21:26 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Canada NewsWire Group</newstex:Publication><title>Oncolytics Biotech Inc. Announces Issuance of 30th U.S. Patent</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0001-29666459</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">CANCER THERAPEUTICS INC.</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ONCOLYTICS BIOTECH INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">CTHP</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ONC</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ONCY</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item></channel></rss>